Butorphanol Tartrate
Who holds supplier records for Butorphanol Tartrate? 4 organisations hold a current record for Butorphanol Tartrate: an active US FDA Type II Drug Master File. A further 4 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (2), United States (1) and Netherlands (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Butorphanol Tartrate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/butorphanol-tartrate
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Butorphanol Tartrate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Abbvie Inc.United States Company GMP cert on recordActive DMF 8904 · latest filing Dec 1990
- HIKAL LTDIndia Company GMP cert on recordActive DMF 31875 · latest filing Jun 2017
- SRI KRISHNA PHARMACEUTICALS LTDIndia Company GMP cert on recordActive DMF 25670 · latest filing Jan 2012
- TAPI NL BVNetherlandsActive DMF 10385 · latest filing Aug 1993
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (4)
Organisations whose Type II DMFs for Butorphanol Tartrate are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- CURIA WISCONSIN INCInactive DMF 14842 · filed Apr 2000
- USA · Inactive DMF 12921 · filed Mar 1998
- TASMANIAN ALKALOIDS PTY LTDInactive DMF 12119 · filed Sept 1996
- United States · Inactive DMF 9127 · filed May 1991
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Butorphanol Tartrate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL299400).
Chemical identity
- IUPAC name
- (1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol;2,3-dihydroxybutanedioic acid
- Canonical SMILES
- C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O.C(C(C(=O)O)O)(C(=O)O)O
- InChIKey
- GMTYREVWZXJPLF-SXWPHCFWSA-N
- Synonyms
- Butorphanol tartrate, Butorphanol tartrate civ, Butorphanol tartrate preservative free, Dolorex, LEVO-BC-2627 TARTRATE, Moradol, Stadol, Stadol ns, Stadol preservative free, Torbugesic, Torbutrol, AC-26433
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Opioid Agonist/Antagonist
- Mechanism of action
- Competitive Opioid Antagonists; Partial Opioid Agonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Butorphanol Tartrate?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Butorphanol Tartrate: Abbvie Inc. (United States), HIKAL LTD (India), SRI KRISHNA PHARMACEUTICALS LTD (India) and TAPI NL BV (Netherlands). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Butorphanol Tartrate Drug Master Files are active?
Abbvie Inc. (DMF 8904), HIKAL LTD (DMF 31875), SRI KRISHNA PHARMACEUTICALS LTD (DMF 25670) and TAPI NL BV (DMF 10385). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Butorphanol Tartrate records mean?
4 organisations have only inactive Type II DMFs for Butorphanol Tartrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Butorphanol Tartrate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Butorphanol Tartrate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.